Share This Page:   

 

Browse by Clinical Topic:
Select a Topic to Learn More

Featured CME/CE Content:

 

neuroscienceCME Editors' Picks:

Connecting the Dots in Fibromyalgia: Linking the Pathophysiology to Improved Diagnostic, Treatment, and Management Decisions (Part 1 of 5)

neuroscienceCME Multimedia Snack

Premiere Date: Wednesday, November 30, 2011

This activity offers CE credit for:

1. Physicians (CME)
2. Other

All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™

Credit Expiration Date:
Friday, November 30, 2012
Note: Credit Is No Longer Available

Faculty

Lesley M. Arnold, MD (Moderator) Professor of Psychiatry and Behavioral Neuroscience Director, Women's Health Research Program University of Cincinnati College of Medicine Cincinnati, OH

Don L. Goldenberg, MD  Chief of Rheumatology Newton-Wellesley Hospital Newton, MA Professor of Medicine Tufts University School of Medicine Boston, MA

Statement of Need

Fibromyalgia affects 2% to 12% of the adult population in the U.S.(1) and is characterized by widespread muscular and soft tissue pain of varying intensity over time. Many patients have additional symptoms including fatigue, headaches, irritable bowel syndrome, cognitive problems or memory lapses, sleep disturbances, anxiety, and depression. Most patients first present to their primary care physicians with the set of complex, overlapping symptoms.(2) In a recent survey of neuroscienceCME Clinical Compassâ„¢ subscribers, 62.8% of physician respondents lacked confidence in their ability to diagnose and manage fibromyalgia. Education that addresses these diverse symptom domains, as well as comorbid medical and psychiatric conditions, will shift usual clinician thinking about pain and equip physicians and the treatment team with the tools needed to better manage fibromyalgia. This neuroscienceCME Snack will provide guidance on appropriate pharmacotherapy options based on the biological basis of the disorder, as well methods to develop and participate in an interdisciplinary care team that empowers the patient, focuses on treating individual symptoms, and coordinates supportive care.

---

1. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics fibromyalgia in the general population. Arthritis Rheum 1995;38:19-28.
2. Russell IJ, Raphael KG. Fibromyalgia syndrome: presentation, diagnosis, differential diagnosis, and vulnerability. CNS Spectr 2008;13:6-11.

Activity Goal

To change clinical thinking to account for the complexities and comorbidities of patients with fibromyalgia, enabling participants to improve self-efficacy in fibromyalgia management and apply multidisciplinary approaches to treatment that addresses patient expectations and individualizes treatment needs, while engaging the patient in their own self-care.

Learning Objectives

At the end of this CE activity, participants should be able to:

• Apply a multidisciplinary approach to fibromyalgia treatment including individualized treatment with pharmacologic and nonpharmacologic approaches (e.g. exercise, cognitive therapy, self-help, etc.).

Financial Support

Funding for this CME activity is provided by CME Outfitters, LLC.

Target Audience

Physicians and other health care professionals interested in fibromyalgia.

Credit Information

CME Credit (Physicians):
CME Outfitters, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CME Outfitters designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Post-tests, credit request forms, and activity evaluations must be completed online at www.neuroscienceCME.com (click on the Testing/Certification link under the Activities tab-requires free account activation), and participants can print their certificate or statement of credit immediately (80% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit www.neurosciencecme.com/technical.asp.

Disclosure Declaration

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by CME Outfitters, LLC, (CMEO) must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, and planning committee members participating in activities sponsored by CMEO are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
Note: While it offers CME credits, this activity is not intended to provide extensive training or certification in the field.

Dr. Arnold has disclosed that she receives grants/research support from Allergan, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Cypress Bioscience, Inc., Eli Lilly and Company, Forest Laboratories, Inc., Pfizer Inc., and Wyeth Pharmaceuticals. She serves as a consultant to Allergan, Inc., AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Cypress Bioscience, Inc., Eli Lilly and Company, Forest Laboratories, Inc., Pfizer Inc., Sanofi-aventis, Takeda Pharmaceuticals North America, Inc., Theravance, Inc., UCB Pharma, and Wyeth Pharmaceuticals.

Dr. Goldenberg has disclosed that he receives honorarium from Eli Lilly and Company, Forest Laboratories, Inc., and Pfizer, Inc.

Tony Graham, MD (content/peer review) has no disclosures to report.

Sharon Tordoff, CCMEP (planning committee) has no disclosures to report.

Joy Bartnett Leffler, MLA, NASW, CSE (planning committee) has no disclosures to report.

Unlabeled Use Disclosure

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

CME Outfitters, LLC and the faculty do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.

Questions about this activity? Call us at 877.CME.PROS (877.263.7767).